NCT02130778View on ClinicalTrials.gov

Natriuretic Effect of GLP-1in Healthy Non Obese Subjects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Sodium Excretion by Urination
Interventions
DRUG

Synthetic GLP-1 (1.5 pmol/kg/min) dissolved in 500 ml 0.9% saline

infusion of synthetic GLP-1 (1.5 pmol/kg/min) saline

OTHER

500 ml 0.9% saline

infusion of saline

Trial Locations (2)

10000

University hospital Centre Zagreb, Zagreb

10 000

University Hospital Centre, Zagreb

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Clinical Hospital Centre Zagreb

OTHER

NCT02130778 - Natriuretic Effect of GLP-1in Healthy Non Obese Subjects | Biotech Hunter | Biotech Hunter